NCT05728515View on ClinicalTrials.gov

A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 25, 2021

Primary Completion Date

March 4, 2022

Study Completion Date

March 4, 2022

Conditions
Clear Cell Renal Cell Carcinoma
Interventions
DRUG

68Ga-NY104

Patients will undergo PET/CT scans after receiving an intravenous injection of 68Ga-NY104

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT05728515 - A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter